CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.348
+0.023 (1.70%)
Aug 17, 2026, 1:47 PM GMT
CelLBxHealth Financials Overview
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1.15 | 1.35 | 2.86 | 2.19 | 1.04 | 1.01 |
Revenue Growth | -14.73% | -52.80% | 30.92% | 109.99% | 2.76% | 32.94% |
Gross Profit Gross Profit Growth | -0.33 | -0.23 | 0.97 | -0.41 | -0.16 | 0.05 |
Operating Income Operating Income Growth | -7.71 | -14.74 | -14.96 | -19.82 | -25.49 | -16.73 |
Net Income Net Income Growth | -12.94 | -19.51 | -14.23 | -20.13 | -21.69 | -15.01 |
Earnings Per Share EPS Growth | -0.02 | -0.06 | -0.05 | -0.08 | -0.09 | -0.07 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United Kingdom (UK) United Kingdom (UK) Growth | 0.27 | 0.91 | 0.51 | 0.22 | 0.09 |
Europe Excluding United Kingdom Europe Excluding United Kingdom Growth | 0.48 | 0.79 | 0.74 | 0.47 | 0.7 |
North America North America Growth | 0.48 | 0.51 | 0.5 | 0.35 | - |
Rest of World Rest of World Growth | 0.13 | 0.66 | 0.44 | - | - |
Total Total Growth | 1.35 | 2.86 | 2.19 | 1.04 | 1.01 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2.88 | 7.35 | 10.43 | 16.22 | 31.9 | 31.84 |
Total Debt Total Debt Growth | 1.31 | 1.82 | 4.21 | 4.55 | 5 | 2.34 |
Net Cash (Debt) Net Cash Growth | 1.56 | 5.53 | 6.22 | 11.66 | 26.9 | 29.5 |
Net Cash Growth | -71.73% | -10.99% | -46.72% | -56.63% | -8.83% | 8.24% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.02 | 0.02 | 0.04 | 0.11 | 0.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -8.66 | -9.26 | -13.45 | -14.46 | -16.05 | -14.01 |
Capital Expenditures CapEx Growth | -0.16 | -0.22 | -0.4 | -0.61 | -1.72 | -1.67 |
Free Cash Flow Free Cash Flow Growth | -8.83 | -9.48 | -13.84 | -15.07 | -17.77 | -15.68 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -28.91% | -17.10% | 33.82% | -18.66% | -15.66% | 5.33% |
Operating Margin | -669.53% | -1090.97% | -522.71% | -906.68% | -2448.13% | -1651.83% |
Pretax Margin | -1071.61% | -1436.57% | -525.12% | -989.57% | -2347.65% | -1714.02% |
Profit Margin | -1123.44% | -1444.04% | -497.03% | -920.95% | -2083.19% | -1481.93% |
FCF Margin | -766.06% | -701.63% | -483.72% | -689.34% | -1706.82% | -1547.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 13.07 | 9.25 | 11.55 | 14.00 | 126.36 | 276.10 |